| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
GroundWorx is a wireless innovations and water conservation company that has built and is deploying a revolutionary new service that manages golf course water consumption and information using proprietary hardware and software that has been developed.
Trading Cross Connects is a Jersey City, NJ-based company in the Software and Internet sector.
Centerpoint IT is an IT services provider based in Atlanta that offers a complete range of high quality IT services, super quick responsiveness to your needs and a team of highly skilled IT engineers.
WAERlinx Advanced Warehouse Management for NetSuite is a fully- featured, flexible WMS thats built around your business.